Jakub Tolar MD PhD

Hematologic Oncology

President, CEO and Executive Dean at Baylor College of Medicine, Houston, Texas

1 Baylor PlazaHouston, TX 77030

Dr. Tolar is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tolar's full profile Already have an account?

Summary

It is my honor and privilege to serve as the President and CEO of Baylor College of Medicine. To lead this institution entrusted with healing, discovery and the formation of future physicians and scientists is not an administrative charge, it is stewardship of an inheritance shaped by generations of Houstonians, Texans and Americans.

Our true measure is not the labs, clinics and classrooms, but our people—the commitment of our faculty, the creativity of our students, the drive of our staff, and the trust of our patients, their families and communities.

Our four missions—education, research, clinical care and community—are not separate, but one: an inquiry enriches medicine, students sharpens the teachers, and the bedside remains the best clinical school to serve our community. My own life in medicine—as a transplant physician, teacher, and scientist—affirms that this union of missions is irreplaceable.

As dean of University of Minnesota Medical School and co-leader of the M Health Fairview health system, my team led major initiatives spanning clinical transformation, research growth, and the integration of the two. We improved the clinical learning environment for residents and students, made rapid and significant improvement in quality/safety metrics, market share and productivity.

As an NIH funded physician scientist for over 25 years now, I learned that research requires resilience and adaptability, and that medicine best advances through partnerships.

Our obligations do not end at the Texas Medical Center. We will carry academic medicine outward, more broadly to communities across Texas, in clinical trials, education, and clinical service, and I trust that our experience in new models of rural healthcare will aid in that effort.

Baylor College of Medicine has a noble inheritance; its future is nobler still. This future demands our commitment, creativity and drive, and in the weeks and months ahead I look forward to meeting more of you in our Baylor family.

Education & Training

University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2000 - 2003
University of MinnesotaResidency, Pediatrics, 1997 - 2000
University of MinnesotaPh.D., Molecular, Cellular & Developmental Biology and Genetics, 1992 - 1996
Charles University in Prague Faculty of MedicineClass of 1990, Summa Cum Laude
Na Vitezne PlaniB.S., Examination of Maturity, Summa Cum Laude, 1980 - 1984

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MN State Medical License 1999 - 2027
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Best Doctors in America BestDoctors.com, 2012, 2017-2018
Top Doctors Minneapolis St. Paul Magazine, 2010, 2012-2018
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017

Clinical Trials

Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)
COMPLETED
PHASE1, PHASE2
HSCT for High Risk Inherited Inborn Errors
COMPLETED
PHASE2
Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA
COMPLETED
PHASE2, PHASE3

Publications & Presentations

PubMed

Evaluating the Readability of Patient-Facing Online Educational Materials for Pediatric Leukemia and Lymphoma.
Chloe Strege, Simone Intriago Tito, Courtney Popp, William C Miller, Cindy Eide
Pediatric Blood & Cancer. 2026-10-01
1 citations
Contribution of HMGB1 to keratinocyte inflammation in recessive dystrophic epidermolysis bullosa.
Kacey Guenther Bui, Ya-Chu Chang, Wannasiri Chiraphapphaiboon, Jianfeng Wang, Christen L Ebens
JID Innovations. 2026-09-01
CAR19 Tregs treat murine chronic graft-versus-host disease through immune suppression without measurable B cell cytolysis.
Sujeong Jin, Michael C Zaiken, Cameron McDonald-Hyman, Christina R Hartigan, Sara Bolivar-Wagers
JCI Insight. 2026-08-24

Journal Articles

Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho
Heather E Stefanski, Jakub Tolar, The Journal of Immunology
Outcome of Haematopoietic Stem Cell Transplantation in Dyskeratosis Congenita*
Jakub Tolar, MD, British Journal of Haematology
Prediction of DNA-binding propensity of proteins by the ball-histogram method
Szaboova A, KuZelka O, Morales E, Zelezny F, Tolar J, Lect Notes Comput Sc, 1/1/2011

Books/Book Chapters

Data Mining and Medical Knowledge Management: Cases and Applications.
Chapter: Gene Expression Mining Guided by Background Knowledge.
Klema J, Zelezny F, Trajkovski I, Karel F, Cremilleux B, Tolar JEditors: Berka P, Rauch J, Zighed DA.IGI Global2009
Data Mining and Medical Knowledge Management: Cases and Applications.
Chapter: Gene expression data mining guided by genomic background knowledge.
Klema J, Zelezny F, Trajkovski I, Karel F, Cremilleux B, Tolar JEditors: Berka P.IGA Global, IDEA Group Publishing, Hershey, PAEdition 1st,2008

Abstracts/Posters

Plasma and intracellular population pharmacokinetic analysis of fludarabine in pediatric allogeneic hematopoietic cell transplant (alloHCT) recipients.
Long-Boyle J, Sambol N, Dvorak CC, Cowan MJ, Lee S, Huang LS, Horn B, Stricherz M, Tolar J, Orchard P, Jacobson P, Aweeka F, Biol Blood Marrow Transplant, 1/1/2014
Toxic epidermal necrolysis (TEN) in recessive dystrophic epidermolysis bullosa status post hematopoietic stem cell transplant.
Sajic D, Hook K, Tolar J, 89th Canadian Dermatology Association Annual Conference, 1/1/2014
Effects of vitronectin on neural differentiation and proliferation of human iPSC’s in 3D cell culture.
Venhuizen S, Lindborg B, Haider K, Ulrich C, Vegoe A, Subramaniam S, Brekke JH, Dutton J, Tolar J, O’Brien TD, Cornell University Merial-NIH Veterinary Scholars Symposium, 1/1/2014

Lectures

Reduced Intensity Conditioned Bone Marrow Transplant with Post-Transplant Cyclophosphamide and Donor-Derived Mesenchymal Stromal Cell Infusions for Recessive Dystrophi...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Cellular Therapy: Concepts and Plans
Osaka, Japan - 1/14/2014
Immunity in Genetic Disorders, Cancer, and Bone Marrow Transplant
University of Minnesota Children’s Hospital, Minneapolis, MN - 1/11/2014

Other

Biological characterization of naturally occurring mutations in an oncogenic variant of human papillomavirus type 11, PhD thesis, directed by Anthony J. Faras, PhD.
Tolar J
1/1/1996

Press Mentions

Baylor College of Medicine Names Minnesota Med School Dean as New President, CEO January 16th, 2026
Minnesota Doctor Dr. Jakub Tolar Named Baylor College of Medicine's Next President and CEOJanuary 15th, 2026
University of Minnesota Heart Specialists Question Proposed Essentia Health MergerApril 17th, 2025